Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2023-05-04 Report Publication Anno…
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022
Report Publication Announcement Classification · 1% confidence The document is a press release dated May 4, 2023, titled "Mise à disposition du Document d'Enregistrement Universel 2022" (Making available of the 2022 Universal Registration Document). It explicitly states that the 2022 Universal Registration Document (URD) was filed with the AMF (Autorité des Marchés Financiers) on April 28, 2023. The URD contains the annual financial report, management report, and auditor reports. Since this document is an announcement *about* the availability of a major annual filing (the URD, which encompasses the 10-K equivalent information for French reporting), and its length is relatively short (4187 characters), it fits the definition of a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) itself. The mention of the upcoming Annual General Meeting (AGM) on June 29, 2023, is secondary to the primary purpose of announcing the URD filing.
2023-05-04 French
DOCUMENT D'ENREGISTREMENT UN IVERSEL 2022
Annual Report (ESEF) Classification · 1% confidence FY 2022
2023-04-28 French
DOCUMENT D'ENREGISTREMENT UN IVERSEL 2022
Annual Report (ESEF) Classification · 0% confidence FY 2022
2023-04-28 French
EQUASENS : Atoopharm, le spécialiste e-learning de la formation officinale, rejoint le Groupe Equasens.
M&A Activity Classification · 1% confidence The document is a press release dated April 6, 2023, announcing that Atoopharm, an e-learning specialist for pharmacy training, has been acquired by Groupe Equasens. This type of announcement, detailing a significant corporate transaction (acquisition/merger), falls under the category of M&A Activity (TAR). It is not a formal regulatory filing like a 10-K, an earnings release, or a proxy statement. It is a specific corporate event announcement.
2023-04-06 French
EQUASENS : Acquisitions de Pratilog et Speech2Sense
M&A Activity Classification · 1% confidence The document is a press release dated April 3, 2023, announcing that the Equasens Group has acquired two companies, Pratilog and Speech2Sense, to strengthen its Medical Solutions Division. This type of announcement, detailing corporate development through acquisitions, is typically classified as a significant corporate event. Since there is no specific category for M&A announcements that are not takeover bids (TAR), and this is a formal announcement of a strategic business development, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate update, or potentially 'Capital/Financing Update' (CAP) if the focus was purely on the financing structure, but M&A is the primary theme. Given the options, and that this is a press release detailing strategic acquisitions, RNS is the most appropriate fallback for a non-standard filing, although it strongly relates to corporate strategy/M&A. However, looking closely at the definitions, TAR is for 'merger proposals or takeover bids'. This is an acquisition announcement. Since it is a formal, immediate announcement of a major corporate action (acquisition), and not a periodic financial report, RNS is the safest general regulatory filing category if TAR is strictly limited to hostile/merger bids. Given the context of financial reporting databases, M&A activity announcements often fall under a specific code. Since TAR is defined as 'merger proposals or takeover bids', and this is an acquisition, I will lean towards RNS as the general regulatory announcement category for corporate actions not explicitly covered, as it is a press release format.
2023-04-03 French
EQUASENS : Résultat Net 2022 : +18,35% à 48,70 M€
Earnings Release Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and details the company's financial results for the full year 2022 (Chiffre d'affaires, Résultat Net, etc.). It highlights key performance indicators and proposes a dividend for the upcoming AGM. This format, focusing on the immediate release of annual financial performance figures, aligns perfectly with the definition of an Earnings Release (ER), even though it covers a full year rather than a quarter. While it contains elements that might appear in a 10-K (like audited accounts being finalized), the document itself is the initial, summarized announcement of those results, making ER the most appropriate classification for this press release format. It is not the full 10-K report itself, nor is it a transcript or a formal audit report. FY 2022
2023-03-24 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.